Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;17(4):1123-1125.
doi: 10.1177/19322968231176835. Epub 2023 May 25.

Evaluation of the Tolerability of a Steel Needle and an Adhesive for a Patch Pump

Nina Jendrike  1 , Guido Freckmann  1 , Collin Krauß  1 , Jochen Mende  1 , Delia Waldenmaier  1 , Lutz Heinemann  2 , Zahra Anita Trippe  3 , Sabine Websky  3
Affiliations

Evaluation of the Tolerability of a Steel Needle and an Adhesive for a Patch Pump

Nina Jendrike et al. J Diabetes Sci Technol. 2023 Jul.
No abstract available

Keywords: adhesive; insulin pump; patch pump; steel needle; tolerability; wear comfort.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GF is general manager of the Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT, Ulm, Germany), which carries out clinical studies on the evaluation of BG meters and medical devices for diabetes therapy on its own initiative and on behalf of various companies. GF/IfDT have received speakers’ honoraria or consulting fees in the last 3 years from Abbott, Ascensia, Berlin Chemie, Boydsense, Dexcom, Lilly, Metronom, MySugr, Novo Nordisk, Pharmasens, Roche, Sanofi, Terumo. NJ, CK, JM, and DW are employees of IfDT. SW is an employee of Gerresheimer. AT was an employee of Sensile Medical AG, when the study was conducted. LH is consultant for a number of companies developing novel diagnostic and therapeutic option of the treatment of patients with diabetes.

Figures

Figure 1.
Figure 1.
Visual analog scales (VAS) for pain, itching, wear comfort, and pain by change of needle position (simulated bolus delivery) across 6 calendar days, and 5-point Likert scales (LS) for size of the mock-up, weight of the device, size of the adhesive, and adhesive bond strength after 5 days of use. VAS allowed ratings between 0 (very good) and 100 (very poor), and ratings were grouped into 5 categories (0-20, 21-40, 41-60, 61-80, and 81-100). The Likert scale ranged from 1 (very good) to 5 (unsatisfactory).
See this image and copyright information in PMC

References

    1. Tanenbaum ML, Adams RN, Hanes SJ, et al.. Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use. J Diabetes Sci Technol. 2017;11(3):484-492. - PMC - PubMed
    1. Heinemann L, Walsh J, Roberts R. We need more research and better designs for insulin infusion sets. J Diabetes Sci Technol. 2014;8(2):199-202. - PMC - PubMed
    1. Food and Drug Administration. Assessing adhesion with transdermal delivery systems and topical patches for ANDAs draft guidance for industry. April2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents.... Accessed May 9, 2023.
    1. Kastner JR, Eisler G, Torjman MC, et al.. In vivo study of the inflammatory tissue response surrounding a novel extended-wear kink-resistant insulin infusion set prototype compared with a commercial control over two weeks of wear time [published online ahead of print May 9, 2022]. J Diabetes Sci Technol. doi:10.1177/19322968221093362. - DOI - PMC - PubMed

Publication types